Healthcare Realty (NYSE: HR) outlines 2025 gains, deleveraging and 2026 FFO outlook

Rhea-AI Filing Summary

Healthcare Realty Trust furnished a business update presentation outlining 2025 results, balance sheet progress, and its Healthcare Realty 2.0 strategic plan. The outpatient medical REIT owns 33 million square feet across 562 properties and reported 2025 normalized FFO of $1.61 per share, with same-store cash NOI up 4.8% and occupancy at 92.1%.

Net debt to adjusted EBITDA improved to 5.4x after about $1.2 billion of asset sales, $650 million of term loan repayments, and $250 million of senior note repayments, contributing to $1.4 billion of liquidity and BBB/Baa2 credit ratings. The company right-sized its dividend to $0.24 per quarter (5.2% yield on a $0.96 annualized rate) and repurchased $50 million of stock in January 2026, with $450 million of authorization remaining.

For 2026, guidance calls for normalized FFO of $1.58–$1.64 per share and same-store cash NOI growth of 3.5%–4.5%. Management highlights high occupancy, a largely fixed-rate debt stack with a 3.2% weighted average rate, a 36% total debt-to-assets ratio, and targeted 9%–12% returns on a ~$300 million redevelopment pipeline as key drivers of future earnings growth.

Insights

REIT and income-investing analyst

Healthcare Realty shows steady deleveraging, asset pruning, and moderate 2026 growth targets.

Healthcare Realty Trust emphasizes being a pure-play outpatient medical REIT with strong 2025 operating performance. Same-store cash NOI grew 4.8%, occupancy reached 92.1%, and normalized FFO was $1.61 per share, all while selling roughly $1.2B of assets at a blended 6.7% cap rate.

Balance sheet metrics improved meaningfully: net debt to adjusted EBITDA fell to 5.4x, total debt to assets is 36%, and liquidity stands at $1.4B, with 98% of debt fixed at a 3.2% weighted average rate as of December 31, 2025. Ratings agencies affirm Baa2/BBB with stable outlooks, supporting ongoing access to capital.

The strategic plan focuses on redeploying capital into 9%–12% yield redevelopment projects, joint ventures, and selective share repurchases, after exiting about 20 non-core markets and cutting the dividend to $0.24 per quarter. 2026 guidance for normalized FFO of $1.58–$1.64 per share and same-store NOI growth of 3.5%–4.5% suggests continued, but not explosive, growth, with execution on leasing, redevelopment lease-up, and disciplined capital allocation remaining key variables.

0001360604False00013606042026-02-272026-02-27

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 27, 2026 (February 27, 2026)

Healthcare Realty Trust Incorporated

(Exact name of registrant as specified in its charter)

Maryland

001-35568

20-4738467

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

3310 West End Avenue, Suite 700

Nashville,

Tennessee

37203

(615)

269-8175

(Address of Principal Executive Office and Zip Code)

(Registrant’s telephone number, including area code)

www.healthcarerealty.com

(Internet address)

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Class A Common Stock, $0.01 par value per share

HR

New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On February 27, 2026, Healthcare Realty Trust Incorporated (the "Company") published a business update presentation on its website (www.healthcarerealty.com). A copy of this presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety.

The information included in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended,or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1			Business Update Presentation, dated February 27, 2026.
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Healthcare Realty Trust Incorporated
Date: February 27, 2026			By:			/s/ Daniel Gabbay
						Name: Daniel Gabbay
						Title: Executive Vice President and Chief Financial Officer

Committed to Maximizing Value for All Shareholders FEBRUARY 2026

| 2 Healthcare Realty at a Glance Premier Pure-Play Outpatient Medical REIT 33M Owned Sq. Feet 562 Properties BBB/Baa2 S&P/Moody’s Credit Rating $725M Annualized Adj. EBITDA $10.7B Enterprise Value 90% Top 50 MSAs $6.5B Market Cap 5.2% Dividend Yield (1) 5.4x Net Debt to Adj. EBITDA Bakersfield MOB (Bakersfield, CA) 2100 Church Street (Nashville, TN) One Scottsdale Medical (Phoenix, AZ)Overlake Medical Pavilion (Seattle, WA) Note: Financial and portfolio information as of December 31, 2025, and market data as of February 26, 2026. Please see the Company’s 4Q 2025 Supplemental report for the quarter ended December 31, 2025 for more information. (1) Based on 4Q annualized dividend of $0.96, and closing share price as of February 26, 2026.

| 3 Investment Highlights  Only REIT Focused Exclusively on the Outpatient Medical Sector  Best-In-Class Portfolio that Posted Market-Leading Same Store NOI Growth in 2025  Strong Relationships with Leading National and Regional Health Systems  Sustained Sector Tailwinds Driving Record Level Occupancy, Rent Escalators and Market Rent Growth  Reconstituted Board and Expanded Management Team Committed to Maximizing Value for Shareholders  Significantly Improved Balance Sheet with Net Debt to EBITDA at 5.4x and $1.4B of Liquidity(1)(2)  Accretive Capital Allocation Opportunities Through Reinvesting into Platform, Growth in Joint Ventures and Select Share Repurchases  Compelling Upside Opportunity for Shareholders Through Earnings Growth and the Stock Re-Rating to its Warranted Multiple (1) Annualized Adjusted EBITDA. Utilizes carrying value of debt in the calculation of net debt; for more information on the Company’s calculation of leverage, please see the Company’s 4Q 2025 Supplemental report for the quarter ended December 31, 2025 at www.healthcarerealty.com (2) Liquidity based on cash on hand and unused capacity on Revolving Credit Facility as of December 31, 2025.

SECTION 1 Business Update

| 5 2025 Financial Performance Improvement Across All Key Metrics Compelling Results In-line or Ahead of Initial 2025 Guidance across Key Operational and Financial Objectives FY 2025 YoY Growth Normalized FFO / Share $1.61 +3% SS Occupancy 92.1% +103 bps SS Cash NOI Growth 4.8% +1.9% Net Debt / EBITDA 5.4x (0.7x) 2025 Highlights  Normalized FFO of $1.61 per share  Same store cash NOI growth of +4.8%, driven by 103bps of occupancy growth, tenant retention of 81.5%, and +3.1% cash leasing spreads  Completed ~$1.2B of asset sales at a blended cap rate of 6.7%  5.8M square feet of lease executions, including 1.6M square feet of new leases  Net Debt to Adjusted EBITDA of 5.4x(1), down 0.7x YoY  Repaid $650M of Term Loans and $250M of Senior Notes  Moody's revised outlook to Stable and affirmed Baa2 rating NFFO guidance range of $1.58 – $1.64 Same Store Cash NOI range of 3.50% – 4.50% 2026 Guidance (1) Annualized Adjusted EBITDA. Utilizes carrying value of debt in the calculation of net debt; for more information on the Company’s calculation of leverage, please see the Company’s 4Q 2025 Supplemental report for the quarter ended December 31, 2025.

| 6 Premier Outpatient Medical Platform 92.1% Same Store Occupancy 4.8% Same Store NOI Growth 93% On / Adjacent and Affiliated ~5 Years WALTR ~95% Self-Managed Deep Relationships with Leading Health Systems Associated Health Systems by Rank (% of MOB SF) Concentrated in Top Markets MSA by Rank (% of MOB SF) Northeast 64 Properties 2.8M SF D.C. Corridor 15 Properties 1.1M SF Atlanta 25 Properties 1.3M SF Miami 11 Properties 0.8M SF Central Florida 27 Properties 1.3M SF Charlotte 31 Properties 1.7M SF Raleigh 27 Properties 1.2M SF San Antonio 10 Properties 0.5M SF Houston 27 Properties 2.1M SFAustin 12 Properties 0.8M SF Dallas / Fort Worth 47 Properties 3.5M SF Phoenix 33 Properties 1.4M SF Southern California 31 Properties 1.9M SF Seattle 29 Properties 1.6M SF Denver Region 42 Properties 2.3M SF Nashville 12 Properties 1.2M SF San Francisco 9 Properties 0.6M SF Charleston 8 Properties 0.3M SF Note: Financial and portfolio information as of December 31, 2025. Southern California includes Los Angeles and San Diego MSAs; Northeast includes Albany, New York, Boston, and Hartford MSAs; Central Florida includes Tampa and Orlando MSAs, Denver Region includes Denver and Colorado Springs MSAs, D.C. Corridor includes Baltimore and Washington D.C. MSAs.

| 7 0.3 0.4 0.4 0.4 0.6 0.7 0.7 0.8 0.9 1.1 Providence Health Baptist Memorial Health Care Indiana University Health AdventHealth Wellstar Health System HCA Ascension Health CommonSpirit Advocate Health Baylor Scott & White 170K SF Lease Extension / 25K SF New Leases December 2025 Key Relationships with Leading Health Systems Top Health System Relationships Select Recent Leasing Transactions 64K SF New Leases January 2026 142K SF Lease Extension January 2026 154K SF Lease Renewal February 2026 65K SF New Leases December 2025 92K SF Lease Extension December 2025 Credit Rating AA- / Aa2 AA / Aa2 A- / A3 AA / Aa3 BBB- / Baa2 A+ / A2 AA / Aa2 AA / Aa2 A-2 / -- A / A3 Directly Leased SF (millions) Note: Portfolio information as of December 31, 2025.

| 8 Highly Experienced Board of Directors Strengthened Governance with Significant REIT CEO and Public Investment Experience Retired President and Chief Executive Officer, BRE Properties Connie Moore ’22 Executive Chairman, PREIT; Retired Chief Executive Officer, VEREIT Glenn Rufrano ’24 Chief Executive Officer, Federal Realty Investment Trust Donald Wood ’24 Managing Partner and Senior Portfolio Manager, Terra Firma Asset Management, LLC Jay Leupp ’20 Retired Vice Chairman and CEO, Kimco Realty David Henry ’24 Board Chair; Retired Senior Portfolio Manager and Head of U.S. Real Estate and Trading, Cohen & Steers Thomas Bohjalian ’24 President and Chief Executive Officer, Healthcare Realty Peter Scott ’25 Revamped Board with Relevant Industry, Corporate Strategy, Capital Allocation, Financial, and Governance Experience. Five Board Members have Meaningful REIT CEO Experience

| 9 Deep and Experienced Management Team President and Chief Executive Officer Peter Scott Executive Vice President and Chief Financial Officer Daniel Gabbay Executive Vice President and Chief Operating Officer Rob Hull Executive Vice President and Chief Investment Officer Ryan Crowley Executive Vice President, General Counsel and Secretary Andrew Loope Glenn Preston Senior Vice President Tony Acevedo Senior Vice President Billy May First Vice President Ashley Lynn First Vice President Strategic Finance and Investments TeamExpanded Asset Management Team First Vice President Casey Pileggi Amanda Callaway Senior Vice President, Chief Accounting Officer Laura Carson First Vice President, Investments Jameson Bennett First Vice President, Director of Corporate Finance Chris Stephan Vice President Burney Dawkins Senior Vice President Tonya Scharf Senior Vice President and Senior Legal Counsel Matt Lederer First Vice President, Investments Rob Tanner First Vice President, Technology & Analytics = 2025 – 2026 Hire Enhanced Senior Leadership Team across Operations, Finance and Investments Doris Lo First Vice President, Corporate Finance

| 10 Multi-Year Tailwinds Driving Record Sector Performance Outpatient Medical Sector Boosted by Ageing Population and Limited New Supply Growth Supply Constraints(3) 9 11 13 15 17 19 1Q '18 1Q '19 1Q '20 1Q '21 1Q '22 1Q '23 1Q '24 1Q '25 M illi on s of S F Rapid Growth of 65+ Population(1) 60 80 100 120 140 1999 2003 2007 2011 2015 2019 2023 Outpatient Visits Inpatient Admissions 65+ population averages 7 health visits and $20,000 annual spend, more than 2-3x younger generations Elevated construction costs have led to a rapid decline in development starts (1) Source: OECD.org. (2) Patient Visits / Admissions by Year, Indexed to 1999 (Per 1,000 Population). Source: AHA. (3) Source: Revista Top 100 MSAs as of 4Q 2025. (4) Based on HR leases signed in 4Q 2025. (5) Rent Growth from 4Q 2024 – 4Q 2025. Source: Revista Top 100 MSAs as of 4Q 2025. Unabated shift in care settings from Hospitals to Outpatient Medical facilities across acuity levels    Preference for Outpatient Settings(2) 56 60 64 68 72 76 80 2025 2027 2029 2031 2033 2035 M illi on s 93% Sector Occupancy(3) (Highest Levels in >7 Years) ~3% Rent Escalators(4) (Record Company Level) >3% Market Rent Growth(5) (Above Long-Term Average) 

| 11 Private Markets Recognize Tailwinds and Value in Outpatient Medical Sector Investment Volumes (2015 – 2025) LTV Rate 50 – 60% S + 150 – 200bps 60 – 70% S + 200 – 250bps Record Operating Fundamentals and Lower Borrowing Costs Generating Attractive Risk-Adjusted Returns in Outpatient Medical $0 $4 $8 $12 $16 $20 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 $ in B illi on s ~$10B Average Outpatient Medical Indicative Cap Rates Indicative Cost of Debt Asset Profile Cap Rate Core / “A” Assets ~5.5% – 6.0% Core-Plus ~6.0 – 6.75% Value-Add ~6.75%+ Source: Revista, CBRE, management observations.

| 12 $600 $950 $0.0 $0.0 $29 $120 $629 $500 $300 $500 $1,070 $1,100 $0 $0 $0 $0 2026 2027 2028 2029 2030 2031 2032 2033 2034 Thereafter Term Loans Senior Notes Mortgage Notes Revolver Significantly Improved Balance Sheet Proactively Addressing Near-Term Maturities to Extend Maturity Ladder S&P / Moody’s Credit Rating BBB / Baa2 Stable Total Debt to Total Assets 36% Liquidity(2) $1.4B Net Debt to Adj. EBITDA(3) 5.4x Fixed Rate Debt 98% Weighted Avg. Interest Rate 3.2% Debt Maturity Schedule(1)Key Credit Metrics Open Maturity Windows for Refinancings Note: Financial information as of December 31, 2025. Please see the Company’s 4Q 2025 Supplemental report for the quarter ended December 31, 2025 for more information. (1) Inclusive of extension options. (2) Cash on hand and unused capacity on the Revolving Credit Facility. (3) Annualized Adjusted EBITDA. Utilizes carrying value of debt in the calculation of net debt; for more information on the Company’s calculation of leverage, please see the Company’s 4Q 2025 Supplemental report for the quarter ended December 31, 2025.

| 13 Disciplined Capital Allocation Framework Capital Allocation Focused On Earnings Accretion and Maximizing Shareholder Value  Prioritize financial flexibility through low leverage and high liquidity to enhance optionality within the business  Leverage(1): 5.4x  Liquidity(2): $1.4B  Maintain access to wide breadth of capital sources  Reduce cost of capital and enhance growth and financial flexibility  Selectively deploy free cash flow and balance sheet capacity into earnings accretive investments  Current Priorities:  Redevelopments: 9 – 12% targeted return on cost  Joint venture acquisitions: Enhanced returns through JV fee structure  Selectively consider share repurchases when stock is trading at discount to NAV  $50M of shares repurchased in January 2026; $450M authorization remaining  Returned $385M of capital to shareholders in 2025 via quarterly dividend payments  Dividend yield of 5.2%(3) based on $0.24 quarterly dividend A Maintain Fortress Balance Sheet B Reinvest in Platform C Return Capital to Shareholders (1) Utilizes carrying value of debt in the calculation of net debt; for more information on the Company’s calculation of leverage, please see the Company’s 4Q 2025 Supplemental report for the quarter ended December 31, 2025. (2) Cash on hand and unused capacity on the Revolving Credit Facility as of December 31, 2025. (3) Based on annualized dividend of $0.96, and closing share price as of February 26, 2026.

SECTION 1 Strategic Plan Update

| 15 Rapid Execution of Healthcare Realty 2.0 Strategic Plan Corporate Governance Organizational Platform Restructuring Portfolio Optimization Reprioritized Capital Allocation Balance Sheet Management Achievements to Date Significant Progress on Strategic Plan with Clear Path to Completion Progress   Achieved mid-5x Net Debt / Adj. EBITDA in 4Q 2025(1)  Extended Term Loan and Revolving Credit Facility maturities to 2029 and 2030, respectively, and repaid $900 million Senior Notes and Term Loans in 2025  Moody’s and S&P affirmed Baa2 / BBB ratings with Stable Outlook  Completed restructuring of Asset Management platform with new organizational structure and leasing model  Achieved target $10M of corporate and property-level G&A savings, bringing G&A in-line with peers  Completed ~$1.2B of planned 2025 dispositions at a blended 6.7% cap rate, and exited 14 non-core markets  Achieved robust Same Store portfolio NOI growth of 4.8% in 2025  Right-sized quarterly dividend to $0.24 / share, saving ~$100M cash flow annually  Completed $50M of share buybacks at a meaningful NAV discount  Accelerated high-ROI Redevelopments and opportunistically evaluating accretive JV transactions  Seasoned management team led by new CEO committed to executing Strategic Plan  Enhanced talent across the organization in asset management, finance, and technology  Reduced size of Board from 12 to 7 members     (1) Annualized Adjusted EBITDA. Utilizes carrying value of debt in the calculation of net debt; for more information on the Company’s calculation of leverage, please see the Company’s 4Q 2025 Supplemental report for the quarter ended December 31, 2025.

| 16 Completed Strategic Disposition Program ~$1,150M 2025 Sales(2) ~$500M 2024 Sales Key Markets 2025 Dispositions ~$1.7B Dispositions (1) Based on LQA NOI at time of sale. (2) Includes early 2026 asset sales. ~6.7% Cap Rate (1) 109 Assets Opportunistically Recycled Capital and Exited approx. 20 Non-Priority Markets Disposition Overview Portfolio Geographic Comparison 2024 Dispositions

| 17 Improved Portfolio Characteristics | Current Portfolio vs. Disposition Portfolio Portfolio Optimization Plan Improved Portfolio Quality and Refocused Footprint on Growth-Oriented Markets Improved Portfolio Quality Better Market Demographics Note: Current portfolio represents current Same Store portfolio as of December 31, 2025. Disposition Portfolio represents ~$1.2 billion assets sold since January 1, 2025. (1) YoY growth of trailing twelve month NOI as of December 31, 2025. (2) Based on 5-year (2025-2030) projected population growth on a 10-mile radial distance per asset; weighted average based on Occupied GLA. Source: Claritas. Occupancy NOI Growth(1) 10-Mile Population Growth(2)Concentration in Key Markets 92% 79% Current Portfolio Dispositions 5% 1% Current Portfolio Dispositions 74% 25% Current Portfolio Dispositions 3.4% 2.3% Current Portfolio Dispositions

| 18 Localized Operations Driving Better Financial Results Simplified Asset Management Structure Leading to Better Health System Relationships and Leasing Outcomes  Integrated asset management approach  Operations and leasing execution as a team  Accountability closer to real estate to drive better results  Emphasis on tenant relationships  Cost savings Total Platform: ~350 | Leadership: ~20 Employees COO x 2 Division Leads x 6 Asset Managers Property ManagersLeasing Integrated functions …Leading to Dramatic Improvement in Leasing OutcomesSimplified Asset Management Structure… Reviewed 2,500+ (12M SF) lease executions signed in 2024 and 2025; identified meaningful improvement across key leasing metrics 2024 – 1H 2025 2H 2025 Delta Retention 83.5% 85.7% 220 bps Cash Leasing Spreads 3.2% 3.8% 60 bps IRR ~60% ~85% 2,500 bps Payback Period 16 months 12 months 4 months Source: internal management figures.

| 19 Portfolio Optimization Update ~560 Stabilized and Lease-Up Assets Remaining After Completion of Disposition Program (1) Shows approximate figures of portfolio metrics, includes held for sale assets. (2) Reflects project occupancy of Redevelopments; pro forma for leases signed through January 2026. Stabilized, high quality assets located in top MSAs with healthy operating performance Identified development and redevelopment projects yielding ~9-12% returns High ROI capital investment opportunities to bring occupancy in line with Stabilized portfolio Description Stabilized (1) ~80% of total portfolio Lease-Up: Unstabilized (1) ~15% of total portfolio Re/Development (1) ~5% of total portfolio # Assets NOI SF Occupancy (4Q 2025) Continue to employ active asset management, maintain high occupancy and tenant retention, and maximize lease economics Execute leasing plans to improve occupancy and NOI Invest capital in Redevelopments at attractive yieldsPortfolio Optimization Approach Portfolio Breakdown (Figures rounded for illustrative purposes) ~460 ~95% Occupancy ~$550M ~25M ~75 ~80% % Leased ~$75M ~6M ~25 ~60%(2) % Leased ~$20M ~2M Stabilized NOI N/A ~$95M ~$50 - 55M Same Store Portfolio

| 20 Capital Allocation | Redevelopment Program Overall Redevelopment Portfolio is 60% Leased(1), ~1,000bps Improvement Since 3Q 2025 222 Westchester Ave Before 23 Existing projects ~9% – 12% Incremental yield on cost +1,000bps % Leased since 3Q 2025 (2) 60% Leased (2) ~$300M Total cost Redevelopment Program Overview (1) Huntersville Medical Plaza – Reese (Charlotte, NC) (1) Excludes Development projects. (2) Pro forma for leases signed through January 2026. Capital Regions MOB (Albany, NY) Treasure Coast MOB (Port St. Lucie, FL) 222 Westchester Ave (White Plains, NY)

| 21 Value Upside for Healthcare Realty Shareholders Note: For a reconciliation of the non-GAAP measures referenced herein to the most directly comparable GAAP measures, please see the Company’s Supplemental report for the quarter ended December 31, 2025. (1) Utilizes carrying value of debt in the calculation of net debt; for more information on the Company’s calculation of leverage, please see the Company’s 4Q 2025 Supplemental report for the quarter ended December 31, 2025. (2) Midpoint of ~$1.65 – ~$1.85 range, per July 2025 Strategic Plan. (3) HR NFFO/sh based on mid-point of FY2026 guidance. (4) Peer set includes: ADC, BNL, EPRT, FCPT, FVR, GNL, GTY, LXP, NNN, NTST, O, PINE, STAG, and WPC. (5) Peer set includes: AKR, BRX, BFS, CURB, FRT, IVT, KIM, KRG, PECO, REG, SITC, and UE. (6) Peer set includes: AHR, ARE, CTRE, CHCT, CMRE, DHC, DOC, LTC, MPW, NHI, OHI, SBRA, SILA, UHT, VTR, and WELL. Source: Capital IQ as of February 26, 2026. HR 2.0 Mid-5x 75 – 80% ~$1.75(2) 92% – 93% 65% – 66% 3 – 4% Leverage (1) Payout Ratio NFFO / Share (Year 3 Run-Rate) Total Occupancy NOI Margin SS NOI Growth Fully reduced leverage Right-sized dividend Tracking ahead of schedule 90.4% at YE 2025; +220bps 64.4% at YE 2025; +60bps Exceeding initial growth targets Results (3) …But Still Trading at Discount to Peers and Historical Averages NTM FFOx Executing with Pace and Purpose… (4) (5) (6)    9x 11x 14x 15x 16x HR (June 2025) HR Current Net Lease REITs Retail REITs Healthcare REITs Attractive Growth with Demographic Tailwinds, Superior Balance Sheet and High Occupancy / High Margin Business Model

SECTION 1 Appendix

| 23 Reconciliation of EBITDA (1) Leasing commission amortization is included in the real estate depreciation and amortization add-back for FFO. (2) Timing adjustments to represent a full quarter impact of acquisitions and dispositions. Properties contributed into a joint venture are adjusted at the Company's share. Timing adjustments also include non-recurring impacts due to one- time items recognized in the quarter. (3) Includes loss on derivatives and legal fees related to the amended and restated credit facility. ($ in thousands) Three Months Ended December 31, 2025 Net income (loss) $14,591 Interest expense 48,189 Income taxes 300 Depreciation and amortization 127,408 Unconsolidated JV depreciation, amortization and interest 8,121 EBITDA $198,609 Transaction costs 300 Gain on sales assets (135,711) Impairments on real estate assets 105,706 Restructuring and severance-related charges 588 Loss on extinguishment of debt 165 Debt Covenant EBITDA $169,657 Leasing commission amortization (1) 8,418 Lease intangibles, franchise taxes and prepaid ground amortization (31) Timing impact (2) (2,089) Stock based compensation 3,308 Allowance for credit losses 100 Rent reserves, net 582 Debt financing costs (3) 1,449 Unconsolidated JV adjustments 319 Adjusted EBITDA $181,713 Annualized Adjusted EBITDA $726,852

| 24 Legal Disclaimer This presentation contains disclosures that are “forward-looking statements” relating to Healthcare Realty Trust Incorporated (the “Company”). Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as “may,” “will,” “expect,” “believe,” “anticipate,” “target,” “intend,” “plan,” “estimate,” “project,” “continue,” “should,” “could," "budget" and other comparable terms. These forward-looking statements are based on the Company's current plans, objectives, estimates, expectations and intentions and inherently involve significant risks and uncertainties. Such risks and uncertainties include, among other things, the following: the Company’s expected results may not be achieved; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; pandemics or other health crises; variability in interest rates; the availability and cost of capital at expected rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to release space at similar rates as vacancies occur; the Company's ability to renew expiring leases; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions, developments, and redevelopments; changes in rules or practices governing the Company's financial reporting; the Company may be required under purchase options to sell properties and may not be able to reinvest the proceeds from such sales at rates of return equal to the return received on the properties sold; uninsured or underinsured losses related to casualty or liability; the incurrence of impairment charges on its real estate properties or other assets; other legal and operational matters; and other risks and uncertainties affecting the Company, including those described from time to time under the caption “Risk Factors” and elsewhere in the Company’s filings and reports with the Securities and Exchange Commission (the “SEC”), including the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and as may be updated in the Company’s quarterly reports on Form 10-Q filed thereafter. Moreover, other risks and uncertainties of which the Company is not currently aware may also affect the Company's forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements, even if they are subsequently made available by the Company on its website or otherwise. The Company undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made, except as required by law. Investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in the Company’s filings and reports.

Filing Exhibits & Attachments

4 documents

Press Releases

• EX-99.1 EX-99.1 31.9 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.7 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 21.4 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.2 KB